Insights from the ADC Symposium 2026
The ADC Symposium 2026, held in Prague on 16–17 September and organised by TKS event organiser, publisher of Chemistry Today, brought together experts from across the antibody-drug conjugate (ADC) field.
During the on-site event, the Chemistry Today team interviewed selected speakers and industry experts to explore some of the key challenges, developments and opportunities shaping ADC development and manufacturing.
We are now bringing these conversations to our readers through a new series of interviews.
Project Pharmaceutics
Johanna Jil, Customer Relationship Manager at Project Pharmaceutics, shares the company’s expertise in ADC formulation and process development, drawing on more than 15 years of experience in optimising and stabilising ADC molecules. The company supports developers with formulation development, process optimisation for lyophilisation, in-use studies and other technical aspects of clinical administration.
The interview also explores the challenges facing the sector as ADC molecules and manufacturing processes become increasingly complex, highlighting the need for stable formulations and robust processes to support the development of viable products.
Finally, the team explains why formulation and process development expertise is an important contribution to the scientific discussions taking place across the ADC community.
For more information on the ADC Symposium visit the official event website: Home – ADC
